InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Saturday, 02/19/2022 5:20:23 AM

Saturday, February 19, 2022 5:20:23 AM

Post# of 40493
Possible News before or on 3/1/22
WHO-led clinical trial of INO-4800 to be unblinded as early as the end of March and would determine whether the WHO recommends it for use against COVID-19.
According to the WHO, research teams in Colombia, Mali, and the Philippines began recruiting volunteers for the Solidarity Trial Vaccines, which aims to "rapidly evaluate the efficacy and safety of promising new candidate vaccines against COVID-19," in late September 2021.
As of Dec. 22, 2021, over 11,500 people had registered to take part in the project, WHO data showed.
https://focustaiwan.tw/society/202202150024
Jan 31, 2022 INNOVATE Study has started Recruiting in Rwanda, Tunisia.
https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=16121
7117-ppl INNOVATE has completed enrollment in Brazil, Colombia, Philippines since 10/29/2021, in Mexico by now. Very high Omicron attack rate sped up cases.

https://clinicaltrials.gov/ct2/history/NCT04642638?A=9&B=10&C=merged#StudyPageTop

Advaccine provides 2 wk interim readout from homologous and heterologous 4800 trials

https://www.chictr.org.cn/hvshowproject.aspx?id=119337
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News